Worg
Latest round
- Series D
Last raised
- Dec 2025
Total raised
- $240M
Investors
- 16
About Worg
, trading as Worg, operates as a biopharmaceutical company that provides allergy and autoimmune disease products and treatment for allergy sufferers. In March 2021, WuXi Biologics became the strategic partner of the company to establish an allergy treatment platform. Aiwu Xu, the founder of the company, once served as the president and vice chairman of Porton Pharma Solutions Ltd and is a doctor in medicinal chemistry from the Shanghai Institute of the pharmaceutical industry. Jeffrey Su, the COO of the company, has 28 years of R&D experience in pharmaceutical companies and 26 years of experience in biopharmaceutical product development. The company bases PCFiT and Apitope technology platforms to build R&D pipelines for allergy and autoimmune disease indications, including WP1048, WP1049, and WP1073. The PCFiT is for patients with allergic rhinitis, allergic conjunctivitis, and allergic asthma. The Apitope is for patients with autoimmune diseases such as multiple sclerosis, uveitis, myocarditis, and rheumatoid arthritis. In addition, it is also developing a molecular allergy diagnostic platform. The company's revenue is generated revenue by providing allergy and autoimmune disease treatment products and diagnosis services.
Who invested in Worg
16 investors across 5 rounds
See all investors in Worg
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Worg
Who invested in Worg?
Worg has 16 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Worg raised?
Worg has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Worg last raise money?
Worg's most recent round on record is a Series D, in Dec 2025.
What does Worg do?
, trading as Worg, operates as a biopharmaceutical company that provides allergy and autoimmune disease products and treatment for allergy sufferers.
Where is Worg headquartered?
Worg is headquartered in Shanghai, China.
Which VCs invest in companies like Worg?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Worg's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Worg? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.